Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Tofacitinib | Tofacitinib is an orally available JAK3/2/1 inhibitor with IC 50 s of 1, 20, and 112 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Tasocitinib; CP-690550. CAS No. 477600-75-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-40354. |  |
| Tofacitinib | Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). Synonyms: Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550. Grades: >98%. CAS No. 477600-75-2. Molecular formula: C16H20N6O. Mole weight: 312.37. |  |
| Tofacitinib | Tofacitinib is a novel Janus kinase 3 (JAK3) inhibitor. JAK3 is a critical cytoplasmic tyrosine kinase in the signaling pathways of multiple cytokines (interleukin (IL)-2, -7, -15 and -21) that are associated with various T cell functions. Group: Biochemicals. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)- β -oxo-1-piperidinepropane nitrile; 1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine; CP 690550; Tofacitinib. Grades: Highly Purified. CAS No. 936487-63-7. Pack Sizes: 25mg, 50mg, 100mg. US Biological Life Sciences. |  Worldwide |
| Tofacitinib | Tofacitinib. Uses: For analytical and research use. Group: Impurity standards. CAS No. 477600-75-2. Molecular Formula: C16H20N6O. Mole Weight: 312.38. Catalog: APB477600752. |  |
| Tofacitinib citrate | Tofacitinib citrate. Group: Biochemicals. Alternative Names: 3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 200mg. Molecular Formula: C16H20N6O·C6H8O7. US Biological Life Sciences. | Worldwide |
| Tofacitinib citrate | Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities. Group: Inhibitors. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile; 2-Hydroxy-1,2,3-propanetricarboxylate. CAS No. 540737-29-9. Molecular formula: C22H28N6O8. Mole weight: 504.4986. Purity: 0.96. Catalog: ACM540737299. |  |
| Tofacitinib citrate | Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC 50 s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Tasocitinib citrate; CP-690550 citrate. CAS No. 540737-29-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-40354A. | |
| Tofacitinib Citrate Liposome | Tofacitinib Citrate (TOF) is a JAK3 inhibitor that achieves efficacy in treating rheumatoid arthritis by inhibiting the intracellular target Janus kinases (JAKs). This product is a pre-formulated liposome encapsulating Tofacitinib Citrate. It is only for research purposes. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| Tofacitinib Impurity 17 | Tofacitinib Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine. CAS No. 1812890-23-5. Molecular Formula: C13H23Cl2N5. Mole Weight: 320.26. Catalog: APB1812890235. | |
| Tofacitinib Impurity 36 | Tofacitinib Impurity 36. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2504210-41-5. Molecular Formula: C29H38N10O2. Mole Weight: 558.69. Catalog: APB2504210415. | |
| Tofacitinib impurity 45 | Tofacitinib impurity 45. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2106832-55-5. Molecular Formula: C14H23ClN2. Mole Weight: 254.8. Catalog: APB2106832555. | |
| Tofacitinib Impurity 5 | Tofacitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride. CAS No. 1062580-52-2. Molecular Formula: C14H22N2·2HCl. Mole Weight: 291.26. Catalog: APB1062580522. | |
| Tofacitinib Impurity 7 | Tofacitinib Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine. CAS No. 90213-66-4. Molecular Formula: C6H3Cl2N3. Mole Weight: 188.01. Catalog: APB90213664. | |
| Tofacitinib Impurity 8 | Tofacitinib Impurity 8. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-methylpyridin-3-amine. CAS No. 3430-27-1. Molecular Formula: C6H8N2. Mole Weight: 108.14. Catalog: APB3430271. | |
| Tofacitinib Impurity C (Racimic Mixture) | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Molecular formula: C16H20N6O. Mole weight: 312.38. | |
| Tofacitinib Impurity E | Synonyms: (3R,4R)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE; 477600-70-7; cis-1-Benzyl-N,4-dimethylpiperidin-3-amine; (3R,4R)-N,4-Dimethyl-1-benzyl-3-piperidinamine; MFCD09475548; 477600-69-4; 3-PIPERIDINAMINE, N,4-DIMETHYL-1-(PHENYLMETHYL)-, (3R,4R)-; (3R,4R)-(1-BENZYL-4-METHYL-PIPERIDIN-3-YL)-METHYL-AMINE; Tofacitinib Impurity E; Tofacitinib Impurity F; MFCD11978163; TJY7EV26LJ; CIS-(1-BENZYL-4-METHYL-PIPERIDIN-3-YL)-METHYL-AMINE; SCHEMBL352022; AMY4163; DTXSID70659968; NVKDDQBZODSEIN-OCCSQVGLSA-N; CS-B0451; CUA60069; AKOS007930642; AKOS015919918; DS-0688; FS-2942; AC-24272; A25786; EN300-188822; (3R,4R)-1-benzyl-N,4-dimethyl-3-piperidinamine; (3R,4R)-1-Benzyl-N,4-dimethyl piperidin-3-amine; A1-00088; J-504320; (3R,4R)-(1-Benzyl-4-methylpiperidin-3-yl)-methylamine; 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,(3R,4R)-rel-. CAS No. 477600-70-7. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| Tofacitinib Impurity F | Cas No. 384338-23-2. | |
| Tofacitinib Impurity F | Tofacitinib Impurity F. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine. CAS No. 477600-74-1. Molecular Formula: C13H19N5. Mole Weight: 245.32. Catalog: APB477600741. | |
| Tofacitinib Impurity I | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C14H22N2. 2HCl. Mole weight: 291.26. | |
| Tofacitinib Impurity J | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C14H22N2. 2HCl. Mole weight: 291.26. | |
| Tofacitinib Impurity K | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H22N5O3. Mole weight: 332.39. | |
| Tofacitinib Impurity L | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide; 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanamide; Tofacitinib Impurity 25; Tofacitinib impurity L; SCHEMBL17718764; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino)piperidin-1-yl)-3-oxopropanamide; CS-M2251; AKOS037650370; CS-14706; C12680. Molecular formula: C16H22N6O2. Mole weight: 330.39. | |
| Tofacitinib Impurity N | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-methyl-N-((3s,4s)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine. CAS No. 1260614-73-0. Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Impurity N (Citrate) | Tofacitinib Impurity N (Citrate). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate. CAS No. 1809002-40-1. Molecular Formula: C16H22N6O·C6H8O7. Mole Weight: 506.52. Catalog: APB1809002401. | |
| Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3R,4S)) | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-Des-(2-Cyanide-acetyl)-(3R,4S). Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-Des-(2-Cyanide-acetyl)-(3S,4R). Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Impurity O | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine. Molecular formula: C20H25N5. Mole weight: 335.46. | |
| Tofacitinib Impurity P | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-((3S,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine. CAS No. 1252883-90-1. Molecular formula: C20H25N5. Mole weight: 335.46. | |
| Tofacitinib Impurity R | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 4-Chloro-7-tosyl-7h-pyrrolo[2,3-d]pyrimidine. CAS No. 479633-63-1. Molecular formula: C13H10ClN3O2S. Mole weight: 307.76. | |
| Tofacitinib Impurity S | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C27H31N5O2S. Mole weight: 489.64. | |
| Tofacitinib Impurity T | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H18N6O. Mole weight: 310.36. | |
| Tofacitinib Impurity U | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H18ClN5. Mole weight: 297.77. | |
| Tofacitinib Impurity V | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H19ClN6O. Mole weight: 346.82. | |
| Tofacitinib Impurity W | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H18ClN5. Mole weight: 279.77. | |
| Tofacitinib Impurity X | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Impurity Y | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C14H21N5. Mole weight: 259.36. | |
| Tofacitinib Impurity Z | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)-. CAS No. 477600-76-3. Molecular formula: C15H21N5O. Mole weight: 287.37. | |
| Tofacitinib N-hydroxy impurity | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H19N5O. Mole weight: 261.33. | |
| Tofacitinib N-Oxide | Tofacitinib N-Oxide is an impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitib related impuritie 8; 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-. Grades: ≥95%. CAS No. 2028267-73-2. Molecular formula: C16H20N6O2. Mole weight: 328.37. | |
| Tofacitinib related compound 1 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H22N6O2. Mole weight: 330.39. | |
| Tofacitinib Related Compound 10 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Related Compound 11 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C14H20N6O. Mole weight: 288.36. | |
| Tofacitinib Related Compound 12 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C20H25N5. Mole weight: 335.46. | |
| Tofacitinib Related Compound 13 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C20H25N5. Mole weight: 335.46. | |
| Tofacitinib Related Compound 14 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C14H19N5O. Mole weight: 273.34. | |
| Tofacitinib Related Compound 15 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C15H21N5O. Mole weight: 287.37. | |
| Tofacitinib Related Compound 16 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C15H23N5. Mole weight: 273.38. | |
| Tofacitinib related compound 2 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C10H17N3O. Mole weight: 195.27. | |
| Tofacitinib related compound 3 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H18N4O2. Mole weight: 262.31. | |
| Tofacitinib related compound 4 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H20N6O. Mole weight: 312.38. | |
| Tofacitinib related compound 5 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C13H19N5. Mole weight: 245.33. | |
| Tofacitinib Related Compound 6 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C19H21N7O2. Mole weight: 379.42. | |
| Tofacitinib Related Compound 7 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C16H22N6O2. Mole weight: 330.39. | |
| Tofacitinib Related Compound 8 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C29H38N10O2. Mole weight: 558.69. | |
| Tofacitinib Related Compound 9 | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Molecular formula: C34H45N7. Mole weight: 551.78. | |
| Tofacitinib Related Impurity (PF-05579970) | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: PF-05579970. Molecular formula: C15H21N5O. Mole weight: 287.37. | |
| (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity A; 3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grades: >98%. CAS No. 1092578-46-5. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC 50 of 1 nM. Uses: Scientific research. Group: Signaling pathways. CAS No. 1092578-46-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-40354D. | |
| (3S,4R)-Tofacitinib | (3S,4R)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity B; 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grades: >98%. CAS No. 1092578-48-7. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| (3S,4S)-Tofacitinib | (3S,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity C; 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grades: >98%. CAS No. 1092578-47-6. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| CP 690550 Citrate (Potent JAK Inhibitor, Tofacitinib citrate) ((3R,4R)-4-Methyl-3-(methyl-7H-pyrro lo[2,3-d]pyrimidin-4-ylamino)-b-oxo-1-piperidinepro panenitrile citrate) | Potent JAK inhibitor (IC50 values are 1, 20, and 112nm for JAK3, JAK2 and JAK1 respectively). Orally active immunosuppressant; exhibits efficacy in rodent rheumatoid arthritis models. Group: Biochemicals. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| CP-690550 Citrate (Tofacitinib Citrate) | CP-690550 is a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis. Group: Biochemicals. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)- β -oxo-1-piperidinepropane nitrile; 2-Hydroxy-1,2,3-propanetricarboxylate; (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-Hydroxy-1,2,3-propanetricarboxylate; CP 690500-10; CP 690550-10; Tofacitinib Citrate. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Dihydro Tofacitinib Citrate | An impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity; 5,6-Dihydro CP-690550 citrate; 5,6-Dihydro Tofacitinib citrate. Molecular formula: C22H30N6O8. Mole weight: 506.51. | |
| 1-Benzyl-4-methyl-3-(methylamino)piperidine Dihydrochloride | A dihydrochloride salt form of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine;dihydrochloride; 1-benzyl-N,4-dimethylpiperidin-3-amine;dihydrochloride. Grades: 99 %. CAS No. 1228879-37-5. Molecular formula: C14H24Cl2N2. Mole weight: 291.26. | |
| 1-Benzyl-4-methyl-3-piperidinamine | 1-Benzyl-4-methyl-3-piperidinamine is an intermediate of Tofacitinib (T528000); an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. Group: Biochemicals. Grades: Highly Purified. CAS No. 1039738-27-6. Pack Sizes: 250mg, 1g. Molecular Formula: C13H20N2, Molecular Weight: 204.31. US Biological Life Sciences. | Worldwide |
| 3-((3R,4R)-4-methyl-3-(methylamino)piperidin-1-yl)-3-oxopropanenitrile hydrochloride | An impurity of Tofacitinib, a Janus kinase inhibitor that could be used against rheumatoid arthritis. CAS No. 1640971-87-4. Molecular formula: C10H18ClN3O. Mole weight: 231.72. | |
| (3R,4R)-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride | (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine;dihydrochloride; (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine;dihydrochloride. CAS No. 1062580-52-2. Molecular formula: C14H24Cl2N2. Mole weight: 291.26. | |
| (3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine | (3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. CAS No. 1638499-31-6. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: (3S,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine. CAS No. 1638499-33-8. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride | (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: Tofacitinib impurity G; Tofacitinib Impurity 02; cis-1-Benzyl-3-(methylamino)-4-methylpiperidine dihydrochloride. CAS No. 1354486-07-9. Molecular formula: C14H24Cl2N2. Mole weight: 291.3. | |
Our database is helping our users find suppliers everyday.
